台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

MP02-05: High Tumor Mutational Burden as a Predictive Biomarker for Pembrolizumab Efficacy in Metastatic Castration-Resistant Prostate Cancer: A Case Report and Literature Review

2024-12-20 • 觀看: 424 • 回應: 0 • doc
MP02-04: Can pyuria predict Upper tract urothelial carcinoma bladder recurrence ?

2024-12-20 • 觀看: 387 • 回應: 0 • doc
MP02-03: Comparison of Bladder Cuff Excision Method in UTUC

2024-12-20 • 觀看: 394 • 回應: 0 • doc
MP02-02: The ADAMTS1–VCAN–EGFR axis contributes oncogenecity with invasion and anoikis resistance in renal cell carcinoma

2024-12-20 • 觀看: 410 • 回應: 0 • doc
MP01-09: Use of clinical characteristics, cystoscopic findings, and urine biomarkers in predicting satisfactory treatment outcome in women with interstitial cystitis/ bladder pain syndrome

2024-12-20 • 觀看: 401 • 回應: 0 • doc
MP01-08: Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment

2024-12-20 • 觀看: 610 • 回應: 0 • doc
MP01-07: Therapeutic efficacy of intensive multimodal therapy for patients with interstitial cystitis/bladder pain syndrome

2024-12-20 • 觀看: 414 • 回應: 0 • doc
MP01-06: Assessing Multiple Versions of ChatGPT in the Taiwan Urology Board Exam: Accuracy, Speed, and Specific Domain Challenges

2024-12-20 • 觀看: 386 • 回應: 0 • doc
MP01-05: Comparison of expulsive rate of distal ureteral stone throughout medical expulsive therapy (MET) : A Meta-Analysis and Systematic Review

2024-12-20 • 觀看: 401 • 回應: 0 • doc
MP01-04: In Patients with Upper Ureteral Stones and Urosepsis Post-PCN: How many days of antibiotic treatment are sufficient to proceed with URSL?

2024-12-20 • 觀看: 412 • 回應: 0 • doc
MP01-03: Associations between air pollutants and the risk of urolithiasis

2024-12-20 • 觀看: 426 • 回應: 0 • doc
MP01-02: Adjuvant steroid therapy after ureter balloon dilatation for ureter stricture: single center experience

2024-12-20 • 觀看: 378 • 回應: 0 • doc

Prev
46
47
48
49
50
51
52
53
54
55
Next
/ 1052